Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1964
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1975 1
1979 1
1981 2
1983 2
1984 1
1985 1
1987 3
1988 2
1989 9
1990 9
1991 8
1992 14
1993 22
1994 42
1995 38
1996 41
1997 51
1998 51
1999 41
2000 54
2001 61
2002 57
2003 65
2004 49
2005 55
2006 53
2007 65
2008 60
2009 58
2010 82
2011 72
2012 52
2013 81
2014 72
2015 60
2016 67
2017 77
2018 82
2019 74
2020 57
2021 66
2022 60
2023 48
2024 34
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,757 results

Results by year

Filters applied: . Clear all
Page 1
Fibrosis and cancer: A strained relationship.
Piersma B, Hayward MK, Weaver VM. Piersma B, et al. Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188356. doi: 10.1016/j.bbcan.2020.188356. Epub 2020 Mar 5. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32147542 Free PMC article. Review.
To illustrate the role of mechanoreciprocity in tumor evolution we summarize data from breast cancer and pancreatic ductal carcinoma (PDAC) studies, and finish by discussing emerging anti-fibrotic strategies aimed at treating cancer....
To illustrate the role of mechanoreciprocity in tumor evolution we summarize data from breast cancer and pancreatic ductal car …
Overview of breast cancer.
Watkins EJ. Watkins EJ. JAAPA. 2019 Oct;32(10):13-17. doi: 10.1097/01.JAA.0000580524.95733.3d. JAAPA. 2019. PMID: 31513033 Review.
Each year, more than 250,000 women in the United States are diagnosed with invasive breast cancer. Although overall mortality for breast cancer patients has declined, it is still the second most common cause of cancer death in women. This article provides an overvie …
Each year, more than 250,000 women in the United States are diagnosed with invasive breast cancer. Although overall mortality for …
Papillary lesions of the breast.
Kulka J, Madaras L, Floris G, Lax SF. Kulka J, et al. Virchows Arch. 2022 Jan;480(1):65-84. doi: 10.1007/s00428-021-03182-7. Epub 2021 Nov 3. Virchows Arch. 2022. PMID: 34734332 Free PMC article. Review.
Papillary lesions of the breast represent a heterogeneous group of lesions including benign papillomas, papillomas with focal epithelial atypia, fully fledged ductal carcinoma in situ (DCIS) or lobular neoplasia, papillary DCIS, encapsulated papillary carcinomas wit …
Papillary lesions of the breast represent a heterogeneous group of lesions including benign papillomas, papillomas with focal epithel …
Ductal carcinoma in situ of breast: update 2019.
Badve SS, Gökmen-Polar Y. Badve SS, et al. Pathology. 2019 Oct;51(6):563-569. doi: 10.1016/j.pathol.2019.07.005. Epub 2019 Aug 28. Pathology. 2019. PMID: 31472981 Free PMC article. Review.
Ductal carcinoma in situ is a non-invasive form of breast cancer. Its incidence is increasing due to widespread use of mammographic screening. ...
Ductal carcinoma in situ is a non-invasive form of breast cancer. Its incidence is increasing due to widespread use of mammogr
Management of High-Risk Breast Lesions.
Bahl M. Bahl M. Radiol Clin North Am. 2021 Jan;59(1):29-40. doi: 10.1016/j.rcl.2020.08.005. Radiol Clin North Am. 2021. PMID: 33222998 Review.
High-risk breast lesions (HRLs) are a group of heterogeneous lesions that can be associated with a synchronous or adjacent breast cancer and that confer an elevated lifetime risk of breast cancer. ...This article reviews histologic features and clinical prese …
High-risk breast lesions (HRLs) are a group of heterogeneous lesions that can be associated with a synchronous or adjacent breast
Ductal carcinoma in situ current trends, controversies, and review of literature.
Hong YK, McMasters KM, Egger ME, Ajkay N. Hong YK, et al. Am J Surg. 2018 Nov;216(5):998-1003. doi: 10.1016/j.amjsurg.2018.06.013. Epub 2018 Jun 18. Am J Surg. 2018. PMID: 30244816 Review.
Ductal carcinoma in situ (DCIS) is a non-obligate precursor, non-invasive malignancy confined within the basement membrane of the breast ductal system. There is a wide variation in the natural history of DCIS with an estimated incidence of progression to inva
Ductal carcinoma in situ (DCIS) is a non-obligate precursor, non-invasive malignancy confined within the basement membrane of the
Diagnosis and Treatment of Breast Cancer in Men.
Zehr KR. Zehr KR. Radiol Technol. 2019 Sep;91(1):51M-61M. Radiol Technol. 2019. PMID: 31471487 Review.
Breast cancer occurs in about 1% of men, but the number of men receiving a diagnosis is increasing. ...However, some argue that breast cancer in men is a different disease than breast cancer in women. Multiple risk factors, including those with genetic and en
Breast cancer occurs in about 1% of men, but the number of men receiving a diagnosis is increasing. ...However, some argue that br
Advances and controversies in management of breast ductal carcinoma in situ (DCIS).
Farante G, Toesca A, Magnoni F, Lissidini G, Vila J, Mastropasqua M, Viale G, Penco S, Cassano E, Lazzeroni M, Bonanni B, Leonardi MC, Ripoll-Orts F, Curigliano G, Orecchia R, Galimberti V, Veronesi P. Farante G, et al. Eur J Surg Oncol. 2022 Apr;48(4):736-741. doi: 10.1016/j.ejso.2021.10.030. Epub 2021 Nov 9. Eur J Surg Oncol. 2022. PMID: 34772587 Review.
Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer. It accounts for 25% of all breast cancers diagnosed, as a result of the expansion of breast cancer screening and is associated with a high survival rate. ...
Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer. It accounts for 25% of all breast
Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls.
Cimino-Mathews A. Cimino-Mathews A. Mod Pathol. 2021 Jan;34(Suppl 1):62-77. doi: 10.1038/s41379-020-00697-3. Epub 2020 Oct 27. Mod Pathol. 2021. PMID: 33110239 Free article. Review.
Immunohistochemistry assists in supporting breast origin for primary or metastatic carcinomas and identifying non-mammary metastases to the breast; however, no single immunostain is perfectly sensitive nor specific. ...In addition, PD-L1 immunohistochemistry is an e …
Immunohistochemistry assists in supporting breast origin for primary or metastatic carcinomas and identifying non-mammary metastases …
Beyond BI-RADS: Nonmass Abnormalities on Breast Ultrasound.
Tsunoda H, Moon WK. Tsunoda H, et al. Korean J Radiol. 2024 Feb;25(2):134-145. doi: 10.3348/kjr.2023.0769. Epub 2024 Jan 10. Korean J Radiol. 2024. PMID: 38238012 Free PMC article. Review.
Abnormalities on breast ultrasound (US) images which do not meet the criteria for masses are referred to as nonmass lesions. ...However, the term "nonmass" is not included in the American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS) …
Abnormalities on breast ultrasound (US) images which do not meet the criteria for masses are referred to as nonmass lesions. ...Howev …
1,757 results